Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes

Diabetologia

Volumn 52, Issue 11, 2009, Pages 2324-2327

  Swinnen, S G H A ^a   Devries, J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Basal insulin preparations; Glycaemic control; Insulin initiation; Insulin therapy; Type 2 diabetes

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CLINICAL TRIAL; CONSULTATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TELECONSULTATION; TREATMENT OUTCOME; WEIGHT GAIN;

COMMUNICATION; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROFESSIONAL-PATIENT RELATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 70349858024     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1527-0     Document Type: Article

References (15)

1. DM Nathan JB Buse MB Davidson, et al. 2009 Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193 203 18945920 10.2337/dc08-9025 1:CAS:528:DC%2BD1MXhs1Gns78%3D
2. FG Eliaschewitz C Calvo H Valbuena, et al. 2006 Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride Arch Med Res 37 495 501 16715577 10.1016/j.arcmed.2005.10.015 1:CAS:528:DC%2BD28Xjs1Wnur8%3D (Pubitemid 43675739)
3. A Fritsche MA Schweitzer HU Häring 2003 Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes Ann Intern Med 138 952 959 12809451 1:CAS:528:DC%2BD3sXlt1CnsLw%3D
4. K Hermansen M Davies T Derezinski, et al. 2006 A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetes Care 29 1269 1274 16732007 10.2337/dc05-1365 1:CAS:528:DC%2BD28XmtFKlsr4%3D (Pubitemid 44125921)
5. MC Riddle J Rosenstock J Gerich 2003 The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 3080 3086 14578243 10.2337/diacare.26.11.3080 1:CAS:528:DC%2BD3sXpsFert70%3D (Pubitemid 37339502)
6. J Rosenstock M Davies P Home J Larsen C Koenen G Schernthaner 2008 A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes Diabetologia 51 408 416 18204830 10.1007/s00125-007-0911-x 1:CAS:528:DC%2BD1cXhtlyls7c%3D
7. H Yki-Järvinen R Kauppinen-Mäkelin M Tiikkainen, et al. 2006 Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study Diabetologia 49 442 451 16456680 10.1007/s00125-005-0132-0 (Pubitemid 43277866)
8. H Yki-Järvinen A Dressler M Ziemen HOE 901/3002 study group 2000 Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes Diabetes Care 23 1130 1136 10937510 10.2337/diacare.23.8.1130
9. K Esposito M Ciotola MI Maiorino, et al. 2008 Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial Ann Intern Med 149 531 539 18936501
10. CY Pan P Sinnassamy KD Chung KW Kim 2007 Insulin glargine vs NPH insulin therapy in Asian type 2 diabetes patients Diabetes Res Clin Pract 76 111 118 17011662 10.1016/j.diabres.2006.08.012 1:CAS:528:DC%2BD2sXhvVCktrs%3D (Pubitemid 46240371)
11. E Standl S Maxeiner S Raptis HOE 901/4009 study group 2006 Once-daily insulin glargine administration in the morning compared to bedtime in combination with morning glimepiride in patients with type 2 diabetes: an assessment of treatment flexibility Horm Metab Res 38 172 177 16673208 10.1055/s-2006-925222 1:CAS:528:DC%2BD28XlvVCit70%3D
12. EAM Gale SD Beattie J Hu V Koivisto MH Tan 2007 Recruitment to a clinical trial improves glycemic control in patients with diabetes Diabetes Care 30 2989 2992 17804681 10.2337/dc07-0155 (Pubitemid 350255230)
13. JH DeVries FJ Snoek PJ Kostense RJ Heine 2003 Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial-mechanisms and implications Diabetes Metab Res Rev 19 357 362 12951643 10.1002/dmrr.405 (Pubitemid 37185376)
14. Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL (2008) Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev, Issue 2, Art. no. CD006739. doi: 10.1002/14651858.CD006739.pub2
15. H Yki-Järvinen 2001 Combination therapies with insulin in type 2 diabetes Diabetes Care 24 758 767 11315844 10.2337/diacare.24.4.758